07/21/2020 12:00 AM EDT
Source: European Union, European Centre for Disease Prevention and Control (ECDC). Published: 7/21/2020. The European Union’s Agency for Railways (ERA), the European Commission, and the European Centre for Disease Prevention and Control (ECDC) have developed this 19-page COVID-19 railway protocol, outlining the operational guidelines for the resumption of railway operations in Europe. This protocol reflects the current status of knowledge about the COVID-19 disease and its pandemic effect. (PDF)
07/20/2020 12:00 AM EDT
Source: World Health Organization, Pan American Health Organization (PAHO). Published: 7/20/2020. This one-hour, 20-minute seminar presents the results of the EpiCOVID19 Study: From Oiapoque to Pelotas, the first and, to date, the only large-scale epidemiological study on the prevalence, epidemiology, and social inequalities associated with SARS-CoV-2 infection in three survey rounds in each of Brazil's 133 most representative cities. (Video or Multimedia)
07/17/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 7/17/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the OraRisk COVID-19 RT-PCR test that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
07/16/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 7/16/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the Boston Heart COVID-19 RT-PCR Test that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
07/16/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 7/16/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the xMAP® SARS-CoV-2 Multi-Antigen IgG Assay. The xMAP® SARS-CoV-2 Multi-Antigen IgG Assay is authorized for the detection of IgG antibodies to SARS-CoV-2 in human serum and plasma (dipotassium EDTA). (PDF)
07/16/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 7/16/2020. This quick reference table summarizes the Centers for Disease Control and Prevention (CDC)’s strategies to optimize personal protective equipment (PPE) supplies in healthcare settings, including during the COVID-19 pandemic, and provides links to CDC’s full guidance documents on optimizing supplies. These strategies offer a continuum of options using the framework of surge capacity when PPE supplies are stressed, running low, or absent. (Text)
07/15/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 7/15/2020. This web page, updated on July 15, 2020, applies to all medical first responders, including fire services, emergency medical services, and emergency management officials, who anticipate close contact with persons with suspected or confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in the course of their work. Sections cover recommended infection prevention and control (IPC) practices for routine healthcare delivery during the COVID-19 pandemic, and recommended IPC practices when caring for a patient with suspected or confirmed SARS-CoV-2 infection. (Text)
07/15/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 7/15/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Quest Diagnostics HA SARS-CoV-2 Assay. The Quest Diagnostics HA SARS-CoV-2 Assay is authorized for use with nasal swab specimens self-collected using a home collection kit under telemedicine supervision for use by individuals suspected of COVID-19 when home collection is determined to be appropriate by a healthcare provider. (PDF)
07/15/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 7/15/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Quest Diagnostics RC SARS-CoV-2 Assay. The Quest Diagnostics RC SARS-CoV-2 Assay is authorized for use with nasal swab specimens self-collected using a home-collection kit under telemedicine supervision for use by individuals suspected of COVID-19 when home collection is determined to be appropriate by a healthcare provider. (PDF)
07/15/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 7/15/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Quest Diagnostics PF SARS-CoV-2 Assay. The Quest Diagnostics PF SARS-CoV-2 Assay is authorized for use with nasal swab specimens self-collected using a home collection kit under telemedicine supervision by individuals suspected of COVID-19 when home collection is determined to be appropriate by a healthcare provider. (PDF)
07/13/2020 12:00 AM EDT
Source: United Nations (UN). Published: 7/13/2020. This web page provides information and links for the launch of the United Nations Secretary-General Independent Accountability Panel (IAP) for Every Woman, Every Child 2020 Report at a high-level political forum side event on July 13, 2020. The 76-page report reviews the status of key Every Woman, Every Child indicators and the implications of COVID-19 on women’s, children’s, and adolescents’ health and rights. It presents country scorecards, analyses of critical challenges and factors for success, and highlights from country case studies. (Video or Multimedia)
07/12/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 7/12/2020. This guidance is for state and local emergency medical planners and all healthcare facilities, especially facilities in rural areas, during the COVID-19 pandemic. It outlines considerations around the transfer of patients, staff, and supplies between healthcare facilities to optimize patient care, balance resources, and minimize use of crisis care standards. One strategy is to identify relief healthcare facilities and either establish a federal, state, or regional Medical Operation Coordination Cell (MOCC) or coordinate with an existing MOCC. This guidance offers considerations for jurisdictions around patient safety and relief healthcare facility operations. (Text)
07/08/2020 12:00 AM EDT
Source: World Health Organization, Pan American Health Organization (PAHO). Published: 7/8/2020. The Pan American Health Organization/World Health Organization (PAHO/WHO) recommends that Member States ensure timely identification of suspect COVID-19 cases; collection and shipment of samples to reference laboratories; and implementation of molecular detection protocols, according to the laboratory capacity. These recommendations are detailed in this 10-page document. (PDF)
07/01/2020 12:00 AM EDT
Source: Healthcare Ready. Published: 7/2020. Healthcare Ready has joined forces with several partners to provide communities (including communities of color and those with marginalized populations) with donations of personal protective equipment, medicines, and critical supplies during the COVID-19 pandemic. This six-page toolkit explains how your community can benefit from the support that Healthcare Ready and its partners are providing. (PDF)
07/01/2020 12:00 AM EDT
Source: National Academies Press (NAP). Published: 7/2020. This 546-page book reviews the state of the evidence on public health emergency preparedness and response (PHEPR) practices and the improvements necessary to move the field forward and to strengthen the PHEPR system. It evaluates PHEPR evidence to understand the balance of benefits and harms of PHEPR practices, with a focus on four main areas of PHEPR: engagement with and training of community-based partners to improve the outcomes of at-risk populations after public health emergencies; activation of a public health emergency operations center; communication of public health alerts and guidance to technical audiences during a public health emergency; and implementation of quarantine to reduce the spread of contagious illness. (Text)
07/01/2020 12:00 AM EDT
Source: United Nations Children's Fund (UNICEF). Published: 7/2020. This 44-page paper reviews the epidemiology of SARS-CoV-2 infection in children and adolescents six months after the COVID-19 pandemic started, susceptibility and transmissibility of infection in children and adolescents, potential for mother-to-child transmission during pregnancy, and clinical manifestations of disease (morbidity and mortality) in children and adolescents, including in relation to pre-existing comorbidities and vulnerabilities. (PDF)
06/30/2020 12:00 AM EDT
Source: National Children's Alliance. Published: 6/30/2020. This 22-page guide is provided to answer questions for children's advocacy center (CAC) staff and multidisciplinary team members on how to maintain health and safety in the CAC setting, to balance the need for pandemic safety against the critical needs of children and families, and to ensure the psychological safety necessary for children to heal and for staff and teams to work effectively. (PDF)
06/29/2020 12:00 AM EDT
Source: National Association of County and City Health Officials (NACCHO). Published: 6/29/2020. Presented in collaboration with the Centers for Disease Control and Prevention (CDC) and U.S. Environmental Protection Agency (EPA), this one-hour, two-minute webinar discusses the parallels seen between COVID-19 response efforts and radiological/nuclear disaster planning. Presenters from CDC and EPA share their observations from recent months regarding COVID-19 communications strategies and social media monitoring findings. (Video or Multimedia)
06/25/2020 12:00 AM EDT
Source: World Health Organization, Pan American Health Organization (PAHO). Published: 6/25/2020. This 10-page guidance presents the existing framework aimed at ensuring that the use of unproven interventions outside of research during an emergency is ethical; discusses the challenges encountered in the use of unproven interventions outside of research during the COVID-19 pandemic in the Region of the Americas; and provides general and operational recommendations to advance during the COVID-19 pandemic the ethical use of unproven interventions outside of research. (PDF)
06/10/2020 12:00 AM EDT
Source: World Health Organization, Pan American Health Organization (PAHO). Published: 6/10/2020. The technical recommendations in this 13-page guide provide information on the methodology for setting up medical coordination and information cells (CICOM, Spanish acronym) as a key function of health emergency operations centers (EOCs). This will facilitate decision-making on how to increase surge capacity during the COVID-19 pandemic through the deployment of emergency medical teams (EMTs) and the installation of alternative medical care sites (AMCS), in cooperation with integrated health services networks and prehospital health care systems. (PDF)
06/05/2020 12:00 AM EDT
Source: Institute for Strategic Dialogue (ISD). Published: 6/5/2020. This eight-page report discusses how legislation and state-based contract tracing efforts have become the focus of significant suspicion, hostility, and opposition, which threaten public health efforts during the COVID-19 pandemic. It details threats to contact tracers, key conspiratorial narratives and influencers, and conspiracy theories. (PDF)
05/01/2020 12:00 AM EDT
Source: World Health Organization, Pan American Health Organization (PAHO). Published: 5/1/2020. The technical recommendations in this 24-page document are designed to guide the steps in the assessment, redesign, and scaling up of new alternative medical care sites (AMCSs) during the COVID-19 pandemic. Users will be able to quickly and methodically locate and determine the viability of new sites. (PDF)
.png)
No hay comentarios:
Publicar un comentario